sur RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
RedChip Hosts Investor Webinar Featuring Lantern Pharma
RedChip Companies announced an upcoming investor webinar featuring Lantern Pharma Inc. Scheduled for August 26, 2025, the event will explore how Lantern is innovating in cancer drug discovery. Central to this discussion is their AI-driven platform, RADR®, capable of analyzing over 200 billion oncology data points. This platform aims to significantly shorten drug development timelines and reduce costs.
Panna Sharma, CEO of Lantern Pharma, will highlight the company's clinical pipeline, which includes promising drugs like LP-300 for NSCLC, LP-184 with potential for solid tumors, and LP-284 targeting aggressive lymphomas. Lantern Pharma boasts collaborations with top cancer centers and an expanding patent portfolio, enhancing its position in the field.
A Q&A session with the management will conclude the presentation. Interested parties can register for the webinar through RedChip’s website.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de RedChip Companies, Inc. (Media Suite)